Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
fda
3
×
life sciences
national blog main
boston
hepatitis b
national top stories
san francisco blog main
alexion pharmaceuticals
aligos therapeutics
alnylam pharmaceuticals
baker brothers life sciences
benzodiazepine
biotech ipos
black diamond therapeutics
blackstone group
bladder cancer
blepharitis
blueprint medicines
boehringer ingelheim
cancer
cancer drugs
cavion
cephalgia
chronic hepatitis b virus
david goldstein
deals
deciphera pharmaceuticals
demodex blepharitis
depression
dicerna pharamceuticals
eli lilly
endometral cancer
epilepsy
essential tremor
europe blog main
european society for medical oncology
What
medicines
3
×
research
3
×
drug
biotech
biotechs
black
cancer
caught
causing
central
clinic
cns
companies
diamond
dicerna
disease
disorder
drugs
eluded
emerged
eye
gene
hepatitis
hopes
intended
ipo
ipos
kept
lead
leading
leads
lines
molecular
nears
nervous
new
pay
pharma
pharmaceuticals
phase
Language
unset
Current search:
medicines
×
fda
×
research
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
